Literature DB >> 7719279

Lipopolysaccharide core region of Hafnia alvei: serological characterization.

C Lugowski1, W Jachymek, T Niedziela, A Romanowska, D Witkowska, E Romanowska.   

Abstract

Covalent glycoconjugates containing, as a ligand lipopolysaccharide core, oligosaccharides of Hafnia alvei standard strain ATCC 13337 and R mutant 1 M were used to produce anti-H. alvei core antibodies. The sera obtained were tested in rocket immunoelectrophoresis, immunoblotting and ELISA using H. alvei lipopolysaccharides of various strains. The experiments were carried out to study the antigenic relationships between lipopolysaccharide core regions in the H. alvei genus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719279     DOI: 10.1111/j.1574-695X.1995.tb00020.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

1.  Concanavalin A binding and endoglycosidase D resistance of beta1,2-xylosylated and alpha1,3-fucosylated plant and insect oligosaccharides.

Authors:  I B Wilson; F Altmann
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

2.  Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.

Authors:  Tomasz Niedziela; Iwona Letowska; Jolanta Lukasiewicz; Marta Kaszowska; Anna Czarnecka; Lennart Kenne; Czeslaw Lugowski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

3.  Structural analysis of the lipid A isolated from Hafnia alvei 32 and PCM 1192 lipopolysaccharides.

Authors:  Jolanta Lukasiewicz; Wojciech Jachymek; Tomasz Niedziela; Lennart Kenne; Czeslaw Lugowski
Journal:  J Lipid Res       Date:  2009-08-25       Impact factor: 5.922

4.  Two Kdo-heptose regions identified in Hafnia alvei 32 lipopolysaccharide: the complete core structure and serological screening of different Hafnia O serotypes.

Authors:  Jolanta Lukasiewicz; Tomasz Niedziela; Wojciech Jachymek; Lennart Kenne; Czeslaw Lugowski
Journal:  J Bacteriol       Date:  2008-11-14       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.